42Stockpicking

PTCT

Ptc Therapeutics Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
8,6
17th %ile · 158p
EV/EBITDAi
P/Bi
P/Si
22,7
79th %ile · 356p
EV/Salesi
23,8
81st %ile · 356p
Div yieldi

Kursudvikling

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026strong
Prishistorik
12,9 år
Pris-dage
3241
Årsregnskaber
16
Peers
0/0
Valuation
3/6
Fundamentals
7/8
Datovindue
2013-06-20 til 2026-05-08

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Kør compute-multiples for manglende valuation metrics.
  • Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.

Seneste assessment

PTCT vurderet 2026-06-10

Score
49.5%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

49%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

39%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

60%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

71%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

66%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

65%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: Own P/E 8.6 vs peer median 12.6; cheaper than peers if business quality is comparable.

Insider activity

Net 90d (aktier)
-91.065
Net 90d (værdi)
-7.085.409 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
20.8.2026SCHMERTZLER MICHAEL▼ SALG-9.419-666.677 USDsec
19.8.2026SCHMERTZLER MICHAEL▼ SALG-5.335-388.708 USDsec
17.8.2026Boulding Mark ElliottEXEC. VP AND CLO▼ SALG-1.844-133.487 USDsec
17.8.2026Boulding Mark ElliottEXEC. VP AND CLO◆ OPT.2.81372.266 USDsec
4.8.2026Klein Matthew B.CHIEF EXECUTIVE OFFICER▼ SALG-10.292-705.722 USDsec
28.7.2026Sollie-Zetlmayer Hege Elisabeth· ANDET4.000sec
14.7.2026Gravier PierreCHIEF FINANCIAL OFFICER▼ SALG-3.494-280.743 USDsec
9.7.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER▼ SALG-2.464-222.376 USDsec
9.7.2026Smith Mary L.▼ SALG-10.000-900.000 USDsec
9.7.2026Smith Mary L.◆ OPT.10.000429.500 USDsec
9.7.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER◆ OPT.2.464114.675 USDsec
7.7.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER▼ SALG-3.956-344.845 USDsec
7.7.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER◆ OPT.24.613970.244 USDsec
6.7.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER▼ SALG-426-36.329 USDsec
6.7.2026Boulding Mark ElliottEXEC. VP AND CLO▼ SALG-313-26.010 USDsec
6.7.2026Boulding Mark ElliottEXEC. VP AND CLO◆ OPT.2.26689.326 USDsec
6.7.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER◆ OPT.81130.899 USDsec
26.6.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER◆ OPT.41215.697 USDsec
26.6.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER▼ SALG-412-35.115 USDsec
25.6.2026Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER▼ SALG-582-49.610 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-0,03-0,44+93.2%+93.2%Beat
2025Q430.1.2026-1,80-0,15-1097.5%-1097.5%Miss
2025Q330.10.20250,19-1,11+116.9%+116.9%Beat
2025Q230.7.2025-0,83-1,06+21.9%+21.9%Beat